Click on a filter below to refine your search. Remove a filter to broaden your search.
A blood-test screener for Alzheimer’s that recently was released on the market may produce too many false positives, a new report warns.
Here are four challenges and their implications that leaders and companies could face that must be addressed if they are to thrive in 2024.
AI developers must learn from the mistakes of EHR adoption, where user interfaces have not always helped clinicians, one expert warns.